Stock Quotes & Company News | Reuters.com
Edition:
United States

People: DURECT Corp (DRRX.O)

DRRX.O on Consolidated Issue listed on NASDAQ Global Market

1.27USD
24 Jun 2016
Change (% chg)

$0.03 (+2.42%)
Prev Close
$1.24
Open
$1.15
Day's High
$1.34
Day's Low
$1.14
Volume
1,737,138
Avg. Vol
511,849
52-wk High
$2.87
52-wk Low
$0.99

Blaschke, Terrence 

Dr. Terrence F. Blaschke, M.D., is an Independent Director of DURECT Corporation, since December 2006. Dr. Blaschke has served on the faculty of Stanford University since 1974 and is Professor of Medicine and Molecular Pharmacology (Emeritus) at the Stanford University School of Medicine. He is currently a senior program officer, Global Health Discovery and Translational Science at the Bill and Melinda Gates Foundation. Dr. Blaschke held the position of Vice President of Methodology and Science at Pharsight Corporation from 2000 to 2002. Dr. Blaschke has served as an independent consultant working with a number of leading pharmaceutical and biotechnology companies. Dr. Blaschke was formerly a board member of Therapeutic Discovery Corporation and Crescendo Pharmaceuticals, two publicly-traded companies. He has also worked as a special government employee for the U.S. Food and Drug Administration (“FDA”) and has served as the chairman of the FDA’s Generic Drugs Advisory Committee. Dr. Blaschke’s medical and scientific expertise and pharmaceutical industry experience as relates to drug development are among the qualifications he brings to the Board and his service as a Director of the Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --